Search

everythinglearnresearchcommunity

for

Search:↓

Systemic diseases can cause hair loss, which is often reversible with treatment.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Low-dose oral minoxidil effectively treats non-scarring hair loss with some side effects like hypertrichosis and postural hypotension.

Some treatments, like corticosteroids and sensitizing agents, can help with alopecia areata, but more high-quality research is needed.

Scalp cooling effectively reduces hair loss from chemotherapy.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

New treatments for hair loss are being developed using molecular biology.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Taxol damages hair growth cells, causing hair loss.

Green tea extract helps prevent cell death and supports cell survival in hair cells exposed to a chemotherapy drug.

Some medications can cause acne, and stopping these drugs is the main treatment.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Hair follicle studies suggest that maintaining telomere length could help treat hair loss and graying, but it's uncertain if mouse results apply to humans.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Up to 50% of women may experience significant hair loss by age 50, with various causes and treatments available.

The book concludes that despite progress, cancer drug treatments have not met the expectations set in the 1960s and 1970s.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Cancer development is like natural selection, involving mutated cells and environmental factors.

Homeopathy helped a 30-year-old man regrow his hair.

Cyclosporine A slows down hair loss from chemotherapy in mice, while dexamethasone increases hair loss but speeds up regrowth.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

The document concludes that understanding and managing hair loss in cancer patients is important, and more research is needed for better treatments.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.